Published 3 days ago • loading... • Updated 3 days ago

BeOne Medicines (ONC) Q2 2026 Earnings Call Transcript

BRUKINSA revenue surged 31% while management raised full-year guidance by $300 million.

BRUKINSA revenue surged 31% while management raised full-year guidance by $300 million.

3 days ago·Alexandria, United States

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left1Leaning Right0Center0Last Updated3 days agoBias Distribution

100% Left

100% Left

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States 3 days ago on Wednesday, August 12, 2026.

Sources are mostly out of (0)

The company also raised full-year operating expense guidance to $2.1 billion to $2.2 billion as it expands manufacturing, trials and launch preparation.